Controlled Breathing for COPD

(REST Trial)

KK
KK
Overseen ByKristina Kashyap
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Texas at Austin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine if a controlled breathing technique, called REST, can reduce stress in people with COPD, a lung disease that makes breathing difficult. Participants will split into two groups: one will practice the REST technique along with receiving COPD education and support, while the other will receive only the education and support. This trial may suit those diagnosed with COPD who frequently feel stressed and do not currently practice breathing exercises. As an unphased trial, this study offers a unique opportunity to explore new stress-reduction techniques tailored for COPD patients.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this controlled breathing intervention is safe for individuals with COPD?

Research shows that breathing exercises can help people with COPD, a lung condition that makes breathing difficult. Studies have found that these exercises can improve lung function and ease physical activity. They can also lessen the disease's impact, enhancing quality of life for those with COPD.

Most people handle these breathing exercises well, with no reports of serious side effects. This suggests the exercises are safe. Therefore, for those considering joining a trial for controlled breathing, current evidence indicates it is a safe option to try.12345

Why are researchers excited about this trial?

Most treatments for COPD focus on medication to open airways or reduce inflammation, like bronchodilators and corticosteroids. However, the REST intervention is unique because it emphasizes controlled breathing techniques as a non-drug approach to managing COPD. Researchers are excited about this trial because they hope to find out if these breathing exercises can improve lung function and quality of life without the side effects often associated with medication. This could offer a new, holistic option for COPD patients seeking alternative or complementary treatments.

What evidence suggests that the REST program is effective for reducing stress in individuals with COPD?

Research shows that controlled breathing exercises can reduce stress in people with COPD (Chronic Obstructive Pulmonary Disease). Studies have found that these exercises improve lung function and slow breathing. One study discovered that combining regular breathing exercises with stretching enhanced lung health in COPD patients. Another study showed that techniques like pursed-lip breathing significantly improved breathing rates compared to not doing these exercises. In this trial, participants in the Behavioral Intervention (REST) arm will receive the REST intervention, which may help manage stress and improve breathing for people with COPD.23456

Are You a Good Fit for This Trial?

This trial is for people over 40 with confirmed COPD, who experience significant stress and shortness of breath. Participants must have a certain score on the COPD Assessment Test, be able to attend training sessions in person, and communicate in English.

Inclusion Criteria

I can attend 2 in-person sessions.
I can read, write, and speak English.
My COPD symptoms are moderate to severe.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the REST (controlled breath) intervention and COPD education

6 months
2 in-person sessions (1 training, 1 trial)

Follow-up

Participants are monitored for acceptability, feasibility, and stress measures

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • REST
Trial Overview The REST trial compares a controlled breathing technique designed to reduce stress against usual care practices for individuals with COPD. It's a pilot study where participants are randomly assigned to one of the two groups.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Intervention (REST)Experimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas at Austin

Lead Sponsor

Trials
387
Recruited
86,100+

Published Research Related to This Trial

The study successfully implemented a province-wide tele-pulmonary rehabilitation (tele-PR) program for individuals with COPD, demonstrating high accessibility and feasibility with over 70% program completion and no major adverse events reported.
Both tele-PR and standard PR showed significant improvements in physical performance and quality of life, with tele-PR participants maintaining better long-term improvements in quality of life scores compared to those in standard PR.
The Accessibility, Feasibility, and Safety of a Standardized Community-based Tele-Pulmonary Rehab Program for Chronic Obstructive Pulmonary Disease: A 3-Year Real-World Prospective Study.Alwakeel, AJ., Sicondolfo, A., Robitaille, C., et al.[2022]
Capnography-assisted respiratory therapy (CART) is a new mind-body approach that effectively integrates real-time CO2 biofeedback with traditional pulmonary rehabilitation (PR) to address dysfunctional breathing behaviors in COPD patients, showing high feasibility with 74% session completion.
Participants in the CART+PR group experienced significant improvements in dyspnea, respiratory rate, and physical function, indicating that this therapy may enhance exercise tolerance and adherence to rehabilitation programs in COPD patients.
Mind-Body Intervention for Dysfunctional Breathing in Chronic Obstructive Pulmonary Disease: Feasibility Study and Lessons Learned.Norweg, AM., Wu, Y., Troxel, A., et al.[2023]
Oxygen supplementation and slow breathing techniques have strong and moderate evidence, respectively, for significantly improving baroreceptor sensitivity (BRS) in patients with chronic obstructive pulmonary disease (COPD), based on a systematic review of 18 studies.
Despite the positive effects on BRS, the long-term therapeutic benefits of these interventions on overall autonomic function in COPD patients remain unclear.
Effect of respiratory rehabilitation techniques on the autonomic function in patients with chronic obstructive pulmonary disease: A systematic review.Mohammed, J., Da Silva, H., Van Oosterwijck, J., et al.[2018]

Citations

Effectiveness of Pulmonary Rehabilitation for Chronic ...The results showed that the PD program was able to improve the activity tolerance level and satisfaction of COPD patients and enrich the ...
Efficacy of respiratory support therapies during pulmonary ...Respiratory support during exercise in COPD patients may be a beneficial adjunct therapy. In this study, the effect of different respiratory ...
Comparing effects of breathing exercises alone and ...The results showed combined routine breathing and breathing-stretching exercises had a better effect on COPD patients' respiratory indicators ( ...
Effect of different exercise programs on lung function in ...Active mind body movement therapy programs were the most effective type of exercise program to improve lung function measured by FEV1 and FEV1%.
Effects of Breathing Exercises in Patients With Chronic ...When compared to the control groups, respiratory rate significantly (p≤0.001) improved in the pursed-lip breathing (PLB), ventilatory feedback ( ...
Breathing Exercises in the Treatment of COPDBreathing exercises in certain can improve pulmonary function, exercise endurance, dyspnea, quality of life, and respiratory muscle strength of COPD patients.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security